Who has invested in Congruence Therapeutics?

OrbiMed, Dimension, Amplitude Ventures, Fonds de solidarité FTQ, Lumira Ventures, IQ are named among the investors backing Congruence Therapeutics.

Congruence Therapeutics Funding: $140M Raised, Series B

Congruence Therapeutics funding overview

Congruence Therapeutics is based in Montreal, Canada. Congruence Therapeutics has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2026. The round record for Congruence Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include OrbiMed, Dimension, Amplitude Ventures, Fonds de solidarité FTQ, Lumira Ventures, IQ and 4 others. 10 distinct backers are named across the disclosed rounds.

Congruence Therapeutics at a glance

Total raised: $140M
Latest round: Series B
Latest round date: March 2026
Headquarters: Montreal, Canada
Notable investors: OrbiMed, Dimension, Amplitude Ventures, Fonds de solidarité FTQ, Lumira Ventures, IQ, BDC Thrive Venture fund, Silver Arc

Frequently asked about Congruence Therapeutics funding

How much has Congruence Therapeutics raised?: Congruence Therapeutics has raised $140M in total disclosed funding across the rounds on record.
Who has invested in Congruence Therapeutics?: OrbiMed, Dimension, Amplitude Ventures, Fonds de solidarité FTQ, Lumira Ventures, IQ are named among the investors backing Congruence Therapeutics.
What was the latest Congruence Therapeutics funding round?: The most recent disclosed round is a Series B, announced in March 2026.
Where is Congruence Therapeutics based?: Congruence Therapeutics is based in Montreal, Canada.
When did Congruence Therapeutics last raise?: The last disclosed Congruence Therapeutics round closed in March 2026 at Series B.

Congruence Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Montreal below to benchmark round size and investor mix.

Congruence Therapeutics Funding: $140M Raised, Series B

Congruence Therapeutics funding overview

Congruence Therapeutics at a glance

Frequently asked about Congruence Therapeutics funding

Companies related to Congruence Therapeutics (36)

Browse related funding lists (6)